Cargando…

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease

SIMPLE SUMMARY: Chagas disease is an infectious condition caused by Trypanosoma cruzi that especially affects the heart; the infected patient may present alterations in heartbeat and an increase in heart volume. When the infection is not treated and remains active for a long time, it can lead to hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisimura, Lindice Mitie, Ferreira, Roberto Rodrigues, Coelho, Laura Lacerda, de Oliveira, Gabriel Melo, Gonzaga, Beatriz Matheus, Meuser-Batista, Marcelo, Lannes-Vieira, Joseli, Araujo-Jorge, Tania, Garzoni, Luciana Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669550/ https://www.ncbi.nlm.nih.gov/pubmed/37998013 http://dx.doi.org/10.3390/biology12111414

Ejemplares similares

Increased angiogenesis parallels cardiac tissue remodelling in experimental acute Trypanosoma cruzi infection
por: Nisimura, Lindice Mitie, et al.
Publicado: (2022)

Effect of benznidazole on cerebral microcirculation during acute Trypanosoma cruzi infection in mice
por: Gonzaga, Beatriz Matheus Souza, et al.
Publicado: (2022)

Acute Chagas Disease Induces Cerebral Microvasculopathy in Mice
por: Nisimura, Lindice Mitie, et al.
Publicado: (2014)

Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins
por: Coelho, Laura Lacerda, et al.
Publicado: (2018)

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach(*)
por: Lannes-Vieira, Joseli
Publicado: (2022)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2015)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Trypanosoma cruzi Promotes Transcriptomic Remodeling of the JAK/STAT Signaling and Cell Cycle Pathways in Myoblasts
por: Nisimura, Lindice M., et al.
Publicado: (2020)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

“Chagas Express XXI”: A new ArtScience social technology for health and science education—A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases
por: Araujo-Jorge, Tania C., et al.
Publicado: (2021)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease
por: Mendes, Veronica G., et al.
Publicado: (2023)

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Resveratrol Reverses Functional Chagas Heart Disease in Mice
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
por: Alvarado-Arnez, Lucia Elena, et al.
Publicado: (2018)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2021)

Influence of Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism in Progression of Chagas Heart Disease
por: Alves, Silvia Marinho Martins, et al.
Publicado: (2020)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease
por: Araujo-Jorge, Tania C., et al.
Publicado: (2022)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2022)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

Tyrosine hydroxylase and β(2)-adrenergic receptor expression in leukocytes of spontaneously hypertensive rats: putative peripheral markers of central sympathetic activity
por: Nisimura, L.M., et al.
Publicado: (2020)

Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis
por: Ferrarini, Mariana Galvão, et al.
Publicado: (2021)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized Trial
por: Holanda, Marcelo T., et al.
Publicado: (2021)

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease
por: Castro, Julia T., et al.
Publicado: (2023)

Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
por: Timm, Bruno Lisboa, et al.
Publicado: (2023)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
por: Oliveira, Ana Carolina, et al.
Publicado: (2023)

Chagas Disease Infection Reactivation after Heart Transplant
por: Moreira, Maria da Consolação Vieira, et al.
Publicado: (2020)

CD8(low) T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers
por: Marins-Dos-Santos, Alessandro, et al.
Publicado: (2020)

Current trends in the pharmacological management of Chagas disease
por: Ribeiro, Vanessa, et al.
Publicado: (2019)

Experimental Social Stress: Dopaminergic Receptors, Oxidative Stress, and c-Fos Protein Are Involved in Highly Aggressive Behavior
por: Felippe, Renata M., et al.
Publicado: (2021)

Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues
por: Silva-dos-Santos, Danielle, et al.
Publicado: (2017)

Electrophysiological characteristics of Chagas disease
por: Cedraz, Swellen Schuenemann, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iu590mfkc82ms98s6t71v2sq7s